Return of research results from pharmacogenomic versus disease susceptibility studies: what’s drugs got to do with it?

od Dressler, Lynn G
izdano v Pharmacogenomics (2012)

Genomics Education for the Public: Perspectives of Genomic Researchers and ELSI Advisors

od Dressler, Lynn G., Jones, Sondra Smolek, Markey, Janell M., Byerly, Katherine W., Roberts, Megan C.
Izdano 2014

Preferences for Return of Incidental Findings from Genome Sequencing Among Women Diagnosed with Breast Cancer at a Young Age

od Kaphingst, Kimberly A., Ivanovich, Jennifer, Biesecker, Barbara B., Dresser, Rebecca, Seo, Joann, Dressler, Lynn G., Goodfellow, Paul J., Goodman, Melody S.
izdano v Clin Genet (2015)

Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance)

od Dressler, Lynn G., Deal, Allison M., Owzar, Kouros, Watson, Dorothy, Donahue, Kathleen, Friedman, Paula N., Ratain, Mark J., McLeod, Howard L.
izdano v J Natl Cancer Inst (2015)

IRB PERSPECTIVES ON THE RETURN OF INDIVIDUAL RESULTS FROM GENOMIC RESEARCH

od Dressler, Lynn G., Smolek, Sondra, Ponsaran, Roselle, Markey, Janell M., Starks, Helene, Gerson, Nancy, Lewis, Susan, Press, Nancy, Juengst, Eric, Wiesner, Georgia L.
Izdano 2012

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study

od O’Brien, Katie M., Cole, Stephen R., Tse, Chiu-Kit, Perou, Charles M., Carey, Lisa A., Foulkes, William D., Dressler, Lynn G., Geradts, Joseph, Millikan, Robert C.
Izdano 2010

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

od Harris, Lyndsay N, Broadwater, Gloria, Lin, Nancy U, Miron, Alexander, Schnitt, Stuart J, Cowan, David, Lara, Jonathan, Bleiweiss, Ira, Berry, Donald, Ellis, Matthew, Hayes, Daniel F, Winer, Eric P, Dressler, Lynn
Izdano 2006

Confronting Real Time Ethical, Legal, and Social Issues in the eMERGE (Electronic Medical Records and Genomics) Consortium

od Clayton, Ellen Wright, Smith, Maureen, Fullerton, Stephanie M., Burke, Wylie, McCarty, Catherine A., Koenig, Barbara A., McGuire, Amy L., Beskow, Laura M., Dressler, Lynn, Lemke, Amy A., Ramos, Erin M., Rodriguez, Laura Lyman
Izdano 2010

Topoisomerase IIα Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of...

od Harris, Lyndsay N., Broadwater, Gloria, Abu-Khalaf, Maysa, Cowan, David, Thor, Ann D., Budman, Daniel, Cirrincione, Constance T., Berry, Donald A., Winer, Eric P., Hudis, Clifford A., Hayes, Daniel F., Friedman, Paula, Ellis, Matthew, Dressler, Lynn
izdano v J Clin Oncol (2009)

Influence of Activation State of ErbB-2 (HER-2) on Response to Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil for Stage II, Node-Positive Breast Cancer: Study 8541 From t...

od DiGiovanna, Michael P., Stern, David F., Edgerton, Susan, Broadwater, Gloria, Dressler, Lynn G., Budman, Daniel R., Henderson, I. Craig, Norton, Larry, Liu, Edison T., Muss, Hyman B., Berry, Donald A., Hayes, Daniel F., Thor, Ann D.
izdano v J Clin Oncol (2008)

Ethical and practical challenges of sharing data from genome-wide association studies: The eMERGE Consortium experience

od McGuire, Amy L., Basford, Melissa, Dressler, Lynn G., Fullerton, Stephanie M., Koenig, Barbara A., Li, Rongling, McCarty, Cathy A., Ramos, Erin, Smith, Maureen E., Somkin, Carol P., Waudby, Carol, Wolf, Wendy A., Clayton, Ellen Wright
Izdano 2011

Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

od Garber, Judy E., Halabi, Susan, Tolaney, Sara M., Kaplan, Ellen, Archer, Laura, Atkins, James N., Edge, Stephen, Shapiro, Charles L., Dressler, Lynn, Paskett, Electra M., Kimmick, Gretchen, Orcutt, James, Scalzo, Anthony, Winer, Eric, Levine, Ellis, Shahab, Nasir, Berliner, Nancy
Izdano 2010

p53 Expression in Node Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B (CALGB) 9344 Trial (159905)

od Lara, Jonathan F., Thor, Ann D., Dressler, Lynn G., Broadwater, Gloria, Bleiweiss, Ira J., Edgerton, Susan, Cowan, David, Goldstein, Lori J., Martino, Silvana, Ingle, James N., Henderson, I. Craig, Norton, Larry, Winer, Eric P., Hudis, Clifford A., Ellis, Matthew J., Berry, Donald A., Hayes, Daniel F.
Izdano 2011

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

od Muss, Hyman B., Berry, Donald A., Cirrincione, Constance T., Theodoulou, Maria, Mauer, Ann M., Kornblith, Alice B., Partridge, Ann H., Dressler, Lynn G., Cohen, Harvey J., Becker, Heather P., Kartcheske, Patricia A., Wheeler, Judith D., Perez, Edith A., Wolff, Antonio C., Gralow, Julie R., Burstein, Harold J., Mahmood, Ahmad A., Magrinat, Gustav, Parker, Barbara A., Hart, Ronald D., Grenier, Debjani, Norton, Larry, Hudis, Clifford A., Winer, Eric P.
Izdano 2009

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

od Esserman, Laura J., Berry, Donald A., DeMichele, Angela, Carey, Lisa, Davis, Sarah E., Buxton, Meredith, Hudis, Cliff, Gray, Joe W., Perou, Charles, Yau, Christina, Livasy, Chad, Krontiras, Helen, Montgomery, Leslie, Tripathy, Debasish, Lehman, Constance, Liu, Minetta C., Olopade, Olufunmilayo I., Rugo, Hope S., Carpenter, John T., Dressler, Lynn, Chhieng, David, Singh, Baljit, Mies, Carolyn, Rabban, Joseph, Chen, Yunn-Yi, Giri, Dilip, van 't Veer, Laura, Hylton, Nola
Izdano 2012

The molecular portraits of breast tumors are conserved across microarray platforms

od Hu, Zhiyuan, Fan, Cheng, Oh, Daniel S, Marron, JS, He, Xiaping, Qaqish, Bahjat F, Livasy, Chad, Carey, Lisa A, Reynolds, Evangeline, Dressler, Lynn, Nobel, Andrew, Parker, Joel, Ewend, Matthew G, Sawyer, Lynda R, Wu, Junyuan, Liu, Yudong, Nanda, Rita, Tretiakova, Maria, Orrico, Alejandra Ruiz, Dreher, Donna, Palazzo, Juan P, Perreard, Laurent, Nelson, Edward, Mone, Mary, Hansen, Heidi, Mullins, Michael, Quackenbush, John F, Ellis, Matthew J, Olopade, Olufunmilayo I, Bernard, Philip S, Perou, Charles M
Izdano 2006

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

od Cavallari, Larisa H., Van Driest, Sara L., Prows, Cynthia A., Bishop, Jeffrey R., Limdi, Nita A., Pratt, Victoria M., Ramsey, Laura B., Smith, D. Max, Tuteja, Sony, Duong, Benjamin Q., Hicks, J. Kevin, Lee, James C., Obeng, Aniwaa Owusu, Beitelshees, Amber L., Bell, Gillian C., Blake, Kathryn, Crona, Daniel J., Dressler, Lynn, Gregg, Ryan A., Hines, Lindsay J., Scott, Stuart A., Shelton, Richard C., Weitzel, Kristin Wiisanen, Johnson, Julie A., Peterson, Josh F., Empey, Philip E., Skaar, Todd C.
izdano v Genet Med (2019)

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

od Muss, Hyman B., Polley, Mei-Yin C., Berry, Donald A., Liu, Heshan, Cirrincione, Constance T., Theodoulou, Maria, Mauer, Ann M., Kornblith, Alice B., Partridge, Ann H., Dressler, Lynn G., Cohen, Harvey J., Kartcheske, Patricia A., Perez, Edith A., Wolff, Antonio C., Gralow, Julie R., Burstein, Harold J., Mahmood, Ahmad A., Sutton, Linda M., Magrinat, Gustav, Parker, Barbara A., Hart, Ronald D., Grenier, Debjani, Hurria, Arti, Jatoi, Aminah, Norton, Larry, Hudis, Clifford A., Winer, Eric P., Carey, Lisa
izdano v J Clin Oncol (2019)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

od Esserman, Laura J., Berry, Donald A., Cheang, Maggie C. U., Yau, Christina, Perou, Charles M., Carey, Lisa, DeMichele, Angela, Gray, Joe W., Conway-Dorsey, Kathleen, Lenburg, Marc E., Buxton, Meredith B., Davis, Sarah E., van’t Veer, Laura J., Hudis, Clifford, Chin, Koei, Wolf, Denise, Krontiras, Helen, Montgomery, Leslie, Tripathy, Debu, Lehman, Constance, Liu, Minetta C., Olopade, Olufunmilayo I., Rugo, Hope S., Carpenter, John T., Livasy, Chad, Dressler, Lynn, Chhieng, David, Singh, Baljit, Mies, Carolyn, Rabban, Joseph, Chen, Yunni-Yi, Giri, Dilip, Au, Alfred, Hylton, Nola
Izdano 2011

Research directions in the clinical implementation of pharmacogenomics - An Overview of US programs and projects

od Volpi, Simona, Bult, Carol J., Chisholm, Rex L., Deverka, Patricia A., Ginsburg, Geoffrey S., Jacob, Howard J., Kasapi, Melpomeni, McLeod, Howard L., Roden, Dan M., Williams, Marc S., Green, Eric D., Rodriguez, Laura Lyman, Aronson, Samuel, Cavallari, Larisa H., Denny, Joshua C, Dressler, Lynn G., Johnson, Julie A., Klein, Teri E., Leeder, J. Steven, Piquette-Miller, Micheline, Perera, Minoli, Rasmussen-Torvik, Laura J., Rehm, Heidi L., Ritchie, Marylyn D., Skaar, Todd C., Wagle, Nikhil, Weinshilboum, Richard, Weitzel, Kristin W., Wildin, Robert, Wilson, John, Manolio, Teri A., Relling, Mary V.
izdano v Clin Pharmacol Ther (2018)